News

Company News & Events

ORYZON to present at upcoming international conferences

27 January 2020

MADRID, SPAIN and CAMBRIDGE MA.

  • BioMed Event, Paris, France
  • 6th Annual LSX World Congress 2020, London, UK
  • Bio-CEO & Investor Conference, New York, USA
  • 13th Annual European LifeSciences CEO Forum, Zurich, Switzerland

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that Executive Directors of the company will present at several reputed international conferences in January-February.

 

Click here to see the full Press Release

 

Posted In: 
News
Investors

Share this story